Edgewise Therapeutics Inc [NASDAQ: EWTX] stock went on a downward path that fall over -8.86% on Thursday, amounting to a one-week price decrease of less than -9.74%.
Over the last 12 months, EWTX stock dropped by -51.09%. The one-year Edgewise Therapeutics Inc stock forecast points to a potential downside of -4129770.13. The average equity rating for EWTX stock is currently 1.40, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $1.37 billion, with 95.21 million shares outstanding and 77.10 million shares in the current float. Compared to the average trading volume of 1.59M shares, EWTX stock reached a trading volume of 3415556 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Edgewise Therapeutics Inc [EWTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EWTX shares is $38.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EWTX stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Edgewise Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 30, 2025. The new note on the price target was released on April 02, 2025, representing the official price target for Edgewise Therapeutics Inc stock. Previously, the target price had yet another raise to $50, while Scotiabank analysts kept a Sector Outperform rating on EWTX stock.
The Price to Book ratio for the last quarter was 2.89, with the Price to Cash per share for the same quarter was set at 4.15.
EWTX Stock Performance Analysis:
Edgewise Therapeutics Inc [EWTX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.74. With this latest performance, EWTX shares dropped by -8.83% in over the last four-week period, additionally sinking by -57.57% over the last 6 months – not to mention a drop of -51.09% in the past year of trading.
Insight into Edgewise Therapeutics Inc Fundamentals:
Return on Equity for this stock declined to -28.98%, with Return on Assets sitting at -28.98%.
EWTX Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EWTX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Edgewise Therapeutics Inc go to -10.60%.
Edgewise Therapeutics Inc [EWTX] Institutonal Ownership Details
There are presently around $104.03%, or 104.48% of EWTX stock, in the hands of institutional investors. The top three institutional holders of EWTX stocks are: ORBIMED ADVISORS LLC with ownership of 15.02 million shares, which is approximately 16.0634%. RA CAPITAL MANAGEMENT, L.P., holding 8.91 million shares of the stock with an approximate value of $$160.45 million in EWTX stocks shares; and RA CAPITAL MANAGEMENT, L.P., currently with $$114.26 million in EWTX stock with ownership which is approximately 6.7844%.
